Observing People With Desmoid-Type Fibromatosis

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Desmoid Fibromatosis Clinical Trial

Official title:
A Prospective Analysis of Active Observation in Patients With Desmoid-Type Fibromatosis

Status Recruiting

Clinical Trial Summary

The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.

n/a

NCT number	NCT04281381
Study type	Observational
Source	Memorial Sloan Kettering Cancer Center
Contact	Aimee M Crago, MD, PhD
Phone	212-639-4807
Email	cragoa@mskcc.org
Status	Recruiting
Phase
Start date	February 19, 2020
Completion date	February 19, 2025

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04195399` - A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery	Phase 2
Completed	`NCT03966742` - Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis	Phase 2
Recruiting	`NCT02402244` - Project: Every Child for Younger Patients With Cancer
Completed	`NCT02066181` - Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis	Phase 3
Active, not recruiting	`NCT02834013` - Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	Phase 2
Not yet recruiting	`NCT06355921` - A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors	N/A